Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Factor VIII concentrate from cold sterilized human plasma.

W Stephan, A M Prince, R Kotitschke

    Developments in Biological Standardization
    |January 1, 1983
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Normal Doppler Reference Values of the Pericallosal Artery.

    Ultraschall in der Medizin (Stuttgart, Germany : 1980)·2015
    Same author

    msABC: a modification of Hudson's ms to facilitate multi-locus ABC analysis.

    Molecular ecology resources·2011
    Same author

    Methodology Used in DNA-Based Prophylactic and Therapeutic Immunization Against Hepatitis B Virus in Chimpanzees.

    Methods in molecular medicine·2011
    Same author

    Fitness effects of derived deleterious mutations in four closely related wild tomato species with spatial structure.

    Heredity·2011
    Same author

    A population genomic approach to map recent positive selection in model species.

    Molecular ecology·2008
    Same author

    Development of the International Consortium for Blood Safety (ICBS) HCV panels.

    Eastern Mediterranean health journal = La revue de sante de la Mediterranee orientale = al-Majallah al-sihhiyah li-sharq al-mutawassit·2008
    Same journal

    International challenges and public policy issues.

    Developments in biological standardization·2000
    Same journal

    Regulation of biologicals in China.

    Developments in biological standardization·2000
    Same journal

    ICH activities on biotech topics.

    Developments in biological standardization·2000
    Same journal

    Regulation of biologicals in the European Union.

    Developments in biological standardization·2000
    Same journal

    Standardisation and licensing of combination vaccines based on DTP.

    Developments in biological standardization·2000
    Same journal

    Control of foot-and-mouth disease by vaccination.

    Developments in biological standardization·2000
    See all related articles

    A modified beta-propiolactone (beta-PL) and UV irradiation method effectively sterilizes factor VIII concentrate, preventing hepatitis B and non-A, non-B transmission in animal studies.

    Area of Science:

    • Virology
    • Biochemistry
    • Hematology

    Background:

    • Beta-propiolactone (beta-PL) with UV irradiation is a standard sterilization technique for factor IX and serum.
    • Factor VIII's sensitivity to beta-PL prevents its use with standard beta-PL/UV sterilization for hepatitis safety.

    Purpose of the Study:

    • To develop a modified beta-PL/UV procedure for sterilizing factor VIII concentrate.
    • To assess the efficacy of this modified procedure in preventing hepatitis B and non-A, non-B virus transmission.

    Main Methods:

    • A modified beta-PL/UV procedure was applied to factor VIII concentrate derived from cryoprecipitate.
    • Experimental animals (chimpanzees) were inoculated with treated and untreated cryoprecipitate and factor VIII concentrate.

    Related Experiment Videos

    Main Results:

    • The modified beta-PL/UV procedure rendered the factor VIII concentrate non-infectious for hepatitis B and non-A, non-B viruses.
    • The original, non-sterilized cryoprecipitate was infectious in experimental animals.

    Conclusions:

    • A modified beta-PL/UV sterilization method can produce hepatitis-safe factor VIII concentrate.
    • This method effectively inactivates both hepatitis B and non-A, non-B viruses in factor VIII preparations.